PALO ALTO, Calif.--(BUSINESS WIRE)--SpeciGen Inc., developer of targeted drug delivery and imaging agents to detect, quantify and deliver therapeutic drugs directly to tumors, is pleased to announce that David Goldsteen, MD, has been appointed to its Board of Directors, bringing the number of Directors to six.
